Statin the course: Navigating unchartered territory in cirrhosis

Hepatol Commun. 2024 Jun 3;8(6):e0456. doi: 10.1097/HC9.0000000000000456. eCollection 2024 Jun 1.

Authors

Camille A Kezer¹, Kathryn A Schmidt, Vijay H Shah

Affiliation

¹ Department of Internal Medicine, Division of Gastroenterology and Hepatology Mayo Clinic 200 First Street, SW Rochester, Minnesota, USA.

No abstract available

Publication types

Editorial
Comment

MeSH terms

Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors* / therapeutic use
Liver Cirrhosis* / complications

Substances

Hydroxymethylglutaryl-CoA Reductase Inhibitors